葡萄球菌肠毒素致敏与哮喘严重程度的纵向研究:EGEA队列
本研究基于EGEA队列的巢式病例对照研究,纳入225名成人(无哮喘75例、轻度哮喘76例、重度哮喘74例),在EGEA1和EGEA2两个时点分析葡萄球菌肠毒素(SE)致敏与哮喘严重程度及急性发作的关联。横断面分析显示SE致敏与重度哮喘风险增加相关;纵向分析显示,EGEA1时的SE致敏与10-20年后重度哮喘(调整OR 2.69,95%CI 1.18-6.15)及哮喘急性发作(调整OR 4.59,95%CI 1.40-15.07)风险增加相关。
要点
- SE致敏在对照组中占39%,轻度哮喘58%,重度哮喘76%(EGEA1)。
- SE致敏与后续重度哮喘风险增加相关(调整OR 2.69,95%CI 1.18-6.15)。
- SE致敏与后续哮喘急性发作风险增加相关(调整OR 4.59,95%CI 1.40-15.07)。
核心结论
- SE致敏与后续重度哮喘及哮喘急性发作风险增加相关。
研究设计与样本
- 巢式病例对照研究,来自20年EGEA队列,纳入225名成人(无哮喘75例、轻度哮喘76例、重度哮喘74例)。
- 其中173人在EGEA1(早11年)有SE致敏检测数据。
- 模型调整性别、年龄、吸烟、父母哮喘/过敏及屋尘螨皮肤点刺试验。
主要发现
- EGEA1时SE致敏比例:对照组39%,轻度哮喘58%,重度哮喘76%。
- 横断面分析显示SE致敏与重度哮喘风险增加相关,与轻度哮喘无关。
- EGEA1时SE致敏与10-20年后重度哮喘相关(调整OR 2.69,95%CI 1.18-6.15)。
- EGEA1时SE致敏与10-20年后哮喘急性发作相关(调整OR 4.59,95%CI 1.40-15.07)。
临床怎么用
- 对哮喘患者可考虑评估SE致敏以识别重度哮喘及急性发作高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Evidence is accumulating that Staphylococcus aureus plays an important role as disease modifier in upper and lower airway diseases. Sensitisation to S. aureus enterotoxins (SEs) was associated with an increased risk of severe asthma in previous cross-sectional studies, but evidence from longitudinal studies is lacking. We aimed to assess associations between SE-sensitisation and the subsequent risk for asthma severity and exacerbations. METHODS: This is a nested case-control study from the 20-year Epidemiological Study of the Genetics and Environment of Asthma (EGEA) cohort, including 225 adults (75 without asthma, 76 with mild asthma and 74 with severe asthma) in EGEA2 (2003-2007). For 173 of these individuals, SE-sensitisation was measured on samples collected 11 years earlier (EGEA1). Cross-sectional associations were conducted for EGEA1 and EGEA2. Longitudinal analyses estimated the association between SE-sensitisation in EGEA1 and the risk of severe asthma and asthma exacerbations assessed in the follow-up. Models were adjusted for sex, age, smoking, parental asthma/allergy and skin-prick test to house dust mite. RESULTS: SE-sensitisation varied between 39% in controls to 58% and 76% in mild and severe asthma, respectively, in EGEA1. An adjusted cross-sectional association showed that SE-sensitisation was associated with an increased risk of severe, but not for mild asthma. SE-sensitisation in EGEA1 was associated with severe asthma (adjusted OR 2.69, 95% CI 1.18-6.15) and asthma exacerbations (adjusted OR 4.59, 95% CI 1.40-15.07) assessed 10-20 years later. CONCLUSION: For the first time, this study shows that being sensitised to SEs is associated with an increased subsequent risk of severe asthma and asthma exacerbations.
引用
- Sintobin I, Siroux V, Holtappels G, et al. Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort. Eur Respir J. 2019. PMID: 31285304. doi:10.1183/13993003.00198-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。